The Online Investor
Adynxx Inc (ALQA)

Adynxx is a technologies company that commercializes differentiated regenerative medical products which assist the body in the repair of human tissue. Co.'s subsidiary, Celleration, Inc. developed the MIST® Ultrasound Healing Therapy (MIST Therapy) therapeutic ultrasound platform for the treatment of acute and chronic wounds. MIST Therapy is a noncontact, low-frequency ultrasound delivered through a saline mist to the wound bed. Co. has a license in intellectual property related to certain placental based products for wound care and wound management, including those made from extracellular matrix derived from the human placenta, and Biovance® Amniotic Membrane Allograft.
Company Name: 
Adynxx Inc
Website: 
www.alliqua.com
Sector: 
Medical Instruments & Supplies
Quotes delayed 20 minutes

Email EnvelopeFree ALQA Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Hold (2.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Adynxx Inc (ALQA) Page | The Online Investor Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.